BALTIMORE, MD, November 12, 2024 – New research in the INFORMS journal Manufacturing & Service Operations Management is guiding the development of more inclusive and efficient electricity markets. The work demonstrates how aggregating small-scale, distributed energy resources (DERs) like solar panels can effectively balance the power of large utility companies.
Global supply chains are undergoing an irrevocable shift. While material flows remain critical, they are only the most visible aspect of this transition. Beneath the surface, changes in information exchanges, financial reconfigurations, and human capital movements are posing far greater risks to the benefits of global trade. The US, China, and the rest the world must handle these changes with care and perspective.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
The Food and Drug Administration and the Centers for Disease Control and Prevention recently authorized a second booster shot of the Pfizer/BioNTech and Moderna COVID-19 vaccines for those age 50 and older. The recommendation follows a study out of Israel recently published in The New England Journal of Medicine.
As the war in Ukraine trudges on and Americans fret over the rising cost of their favorite breakfast cereals, there may be a group that benefits from the chaos and the increasing price of grain: U.S. farmers.
If you’re working from home after spending months, or years, working in an office, you may find it hard to take breaks. Yet don’t get persuaded into thinking that working nonstop is the best approach for your physical and mental health.
Front-of-package symbols appear to have had an effect on breakfast cereal consumers in Chile, prompting them toward healthier products, according to new research.
The World Health Organization (WHO) has raised unspecified concerns about the manufacturing of Covaxin, one of India’s home-grown COVID-19 vaccines. On 2 April, WHO said it had found problems during a March inspection of the production facilities of Bharat Biotech, the vaccine’s producer. WHO did not disclose the nature of the problems at the plant, which is located in Hyderabad, in Telangana state. But it said Bharat Biotech has agreed to stop exports of Covaxin and is “developing a corrective and preventive action plan.”
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine
